Sanofi to Drop Eczema Drug Amid Review of Pipeline Under New CEO
The drugmaker said efficacy and safety data didn’t support further development of the drug, amlitelimab, for atopic dermatitis. Source link
Health
Microplastics detected in most heart attack patients’ blood in startling new study
NEWYou can now listen to Fox News articles! Patients experiencing severe heart attacks may have significantly higher concentrations of micro-
Quit smoking, and your health will improve quickly. But getting better over the long term takes work.
There are steps ex-smokers can take to speed up the healing, but at least some of the damage is likely
Men switched at birth uncover hospital mix-up after DNA test decades later
Men uncover hospital mix-up after DNA test reveals they were switched at birth Jeremy Morrison and Kyle Bylin, born in
An outbreak of cyclosporiasis that’s sickened thousands shouldn’t prevent you from enjoying a Caesar salad—if you take the right precautions
An outbreak of cyclosporiasis that has sickened thousands shouldn’t prevent you from eating any fresh produce, experts say. Source link
FDA to review 7 popular peptides touted for weight loss, healing and longevity
NEWYou can now listen to Fox News articles! The Food and Drug Administration is taking a closer look this week
Eli Lilly Preparing Retatrutide Applications After Positive Weight-Loss Data
Eli Lilly is preparing application materials for its next-generation weight-loss drug, retatrutide, following data from two Phase 3 trials showing
AstraZeneca Wins EU Approval for Breast-Cancer Drug as U.S. Review Continues
The approval opens a big market for camizestrant as U.S. regulators continue to review the company’s application there. Source link
Roche Backs Full-Year View as First-Half Sales Rise
The drugmaker’s sales grew 6% on a constant exchange rate basis and exceeded analysts’ expectations, according to a company compiled
Dassault Systemes to Buy ArisGlobal for Up to $2 Billion
The French company agreed to buy the U.S. supplier of software to the life-sciences industry, seeking to bolster its artificial-intelligence